• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道萎缩最恼人的症状:来自观察性 AGATA 研究的证据。

The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study.

机构信息

Department of Obstetrics and Gynecology and Pediatrics, University of Modena and Reggio Emilia, Modena, Italy.

Department of Obstetrics and Gynecology and Pediatrics, University of Udine, Udine, Italy.

出版信息

Maturitas. 2018 Feb;108:18-23. doi: 10.1016/j.maturitas.2017.11.007. Epub 2017 Nov 10.

DOI:10.1016/j.maturitas.2017.11.007
PMID:29290210
Abstract

OBJECTIVES

Vaginal atrophy (VA) is a chronic medical condition. It is managed unsatisfactorily, despite its high prevalence and negative impact on female quality of life. In order to meet their needs, it would be useful to know what women perceive to be the most bothersome symptom (MBS) of VA.

STUDY DESIGN

Cross-sectional, multicenter study of 913 postmenopausal women consulting 22 gynecological outpatient services.

MAIN OUTCOME MEASURES

Prevalence of the MBS perceived by postmenopausal women of different age and vaginal condition.

RESULTS

Vaginal dryness was the most prevalent MBS (54.4%), followed by dyspareunia (17.6%), itching (7.8%), dysuria (5.9%) and burning (2.0%). The prevalence of vaginal dryness as the MBS increased with years since menopause, while that of itching, dysuria and burning remained approximately constant over time. The prevalence of dyspareunia as the MBS was 26.2% in the first 6 years after menopause and declined thereafter, to 8.8%.

CONCLUSIONS

Among all postmenopausal women vaginal dryness per se, independent of dyspareunia, is the most commonly reported MBS. In each woman, the identification of the MBS may help to define more appropriate VA management.

摘要

目的

阴道萎缩(VA)是一种慢性疾病。尽管其患病率高,对女性生活质量有负面影响,但治疗效果仍不尽人意。为了满足她们的需求,了解女性认为最困扰的 VA 症状(MBS)将很有帮助。

研究设计

对 913 名绝经后妇女进行的横断面、多中心研究,这些妇女咨询了 22 个妇科门诊服务。

主要观察指标

不同年龄和阴道状况的绝经后妇女感知到的 MBS 的患病率。

结果

阴道干燥是最常见的 MBS(54.4%),其次是性交困难(17.6%)、瘙痒(7.8%)、尿痛(5.9%)和灼热感(2.0%)。阴道干燥作为 MBS 的患病率随着绝经后年限的增加而增加,而瘙痒、尿痛和灼热感随时间的推移基本保持不变。绝经后 6 年内,性交困难作为 MBS 的患病率为 26.2%,此后下降至 8.8%。

结论

在所有绝经后妇女中,阴道干燥本身,无论是否伴有性交困难,都是最常报告的 MBS。在每位女性中,确定 MBS 可能有助于确定更合适的 VA 管理方案。

相似文献

1
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study.阴道萎缩最恼人的症状:来自观察性 AGATA 研究的证据。
Maturitas. 2018 Feb;108:18-23. doi: 10.1016/j.maturitas.2017.11.007. Epub 2017 Nov 10.
2
Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.绝经后女性的阴道萎缩。一项多中心观察性研究的结果:AGATA研究。
Maturitas. 2016 Jan;83:40-4. doi: 10.1016/j.maturitas.2015.09.001. Epub 2015 Sep 14.
3
Vaginal atrophy across the menopausal age: results from the ANGEL study.绝经后女性阴道萎缩的研究:ANGEL 研究结果。
Climacteric. 2019 Feb;22(1):85-89. doi: 10.1080/13697137.2018.1529748. Epub 2019 Jan 2.
4
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study.阴道萎缩客观体征与主观症状之间的患病率及相关性:AGATA研究
Menopause. 2016 Oct;23(10):1139-45. doi: 10.1097/GME.0000000000000675.
5
A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.一项评价雌二醇阴道乳膏 0.003%用于绝经后以阴道干燥为最困扰症状的女性的安全性和有效性的随机、多中心、双盲研究。
J Womens Health (Larchmt). 2018 Mar;27(3):231-237. doi: 10.1089/jwh.2017.6515. Epub 2017 Dec 1.
6
Medical and patient attitude towards vaginal atrophy: the AGATA study.医学及患者对阴道萎缩的态度:AGATA研究
Climacteric. 2016 Dec;19(6):553-557. doi: 10.1080/13697137.2016.1240770. Epub 2016 Oct 13.
7
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.四个欧洲国家的外阴和阴道萎缩:来自欧洲REVIVE调查的证据。
Climacteric. 2016 Apr;19(2):188-97. doi: 10.3109/13697137.2015.1107039. Epub 2015 Nov 19.
8
The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.美国和西欧绝经后女性的外阴阴道萎缩症状与生活质量之间的关联
J Womens Health (Larchmt). 2015 Sep;24(9):713-22. doi: 10.1089/jwh.2014.5177. Epub 2015 Jul 22.
9
Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.GSM 相关性交困难:经腹超声测量总阴道厚度的相关性。
J Sex Med. 2019 Dec;16(12):2038-2042. doi: 10.1016/j.jsxm.2019.08.019. Epub 2019 Sep 18.
10
Female sexuality and vaginal health across the menopausal age.女性性健康与绝经期阴道健康
Menopause. 2020 Jan;27(1):14-19. doi: 10.1097/GME.0000000000001427.

引用本文的文献

1
The Effect of Radiofrequency Therapy on Sexual Function in Female Cancer Survivors (Gynecologic and Breast) and Non-cancer Menopausal Women: A Single-Arm Trial.射频治疗对女性癌症幸存者(妇科和乳腺癌)及非癌症绝经后女性性功能的影响:一项单臂试验。
J Lasers Med Sci. 2023 Sep 2;14:e32. doi: 10.34172/jlms.2023.32. eCollection 2023.
2
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats.香桃木蜂蜜对双侧卵巢切除大鼠外阴阴道萎缩(VVA)的调节作用。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1031066. doi: 10.3389/fendo.2023.1031066. eCollection 2023.
3
Modern management of genitourinary syndrome of menopause.
更年期泌尿生殖综合征的现代管理
Fac Rev. 2021 Mar 3;10:25. doi: 10.12703/r/10-25. eCollection 2021.
4
Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use.奥司米芬治疗外阴和阴道萎缩:聚焦于患者可接受性及使用便利性评估
Patient Prefer Adherence. 2020 Jan 10;14:55-62. doi: 10.2147/PPA.S203614. eCollection 2020.
5
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.应对女性外阴阴道萎缩(VVA)/绝经泌尿生殖综合征(GSM)以促进健康衰老
Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019.
6
Treatment of genitourinary syndrome of menopause: the potential effects of intravaginal ultralow-concentration oestriol and intravaginal dehydroepiandrosterone on quality of life and sexual function.更年期泌尿生殖综合征的治疗:阴道内超低浓度雌三醇和阴道内脱氢表雄酮对生活质量和性功能的潜在影响。
Prz Menopauzalny. 2019 Jun;18(2):116-122. doi: 10.5114/pm.2019.86836. Epub 2019 Jun 28.
7
Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.前瞻性外阴-阴道摄影和阴道/外阴健康指数评估欧贝米芬对泌尿生殖健康的影响。
Menopause. 2019 Sep;26(9):994-1001. doi: 10.1097/GME.0000000000001350.
8
Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.在患有中重度阴道干燥的绝经后妇女中奥昔布宁的疗效和安全性:一项 3 期、随机、双盲、安慰剂对照、多中心试验。
Menopause. 2019 Jan 28;26(6):611-621. doi: 10.1097/GME.0000000000001292.